Trial Profile
A multi-center, double-blind, randomized, placebo-controlled, parallel group study to investigate the effect of Pd-217,014 in patients with irritable bowel syndrome (IBS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2006
Price :
$35
*
At a glance
- Drugs PD 217014 (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 10 Aug 2006 Status change
- 19 Nov 2005 New trial record.